| Trial ID: | L4425 |
| Source ID: | NCT01099618
|
| Associated Drug: |
Metformin
|
| Title: |
Ketosis-Prone Diabetes Mellitus (KPDM): Metformin Versus Sitagliptin Treatment
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01099618/results
|
| Conditions: |
Ketosis Prone Diabetes|Diabetes Ketoacidosis|Hyperglycemia
|
| Interventions: |
DRUG: metformin|DRUG: placebo|DRUG: Sitagliptin
|
| Outcome Measures: |
Primary: Length of Remission, For those patients that are able to discontinue insulin therapy at or \<12 weeks, how long were they able to well controlled with an A1c \<7% on the agent that they were randomized to., 3 years |
|
| Sponsor/Collaborators: |
Sponsor: Dawn Smiley MD
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
48
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2010-03
|
| Completion Date: |
2014-08
|
| Results First Posted: |
2015-06-18
|
| Last Update Posted: |
2015-06-18
|
| Locations: |
Grady Memorial Hospital, Atlanta, Georgia, 30303, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01099618
|
